Advances in Alzheimer's Disease (AAD) is an openly accessible journal published quarterly. The goal of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of Alzheimer's Disease. All manuscripts must be prepared in English and are subject to a rigorous peer-review process. Generally, accepted papers will appear online within 3 weeks followed by printed hard copy.

The areas of Advances Alzheimer's Disease (AAD) include but are not limited to the following fields:

• · Alzheimer's Disease and Down Syndrome
• · Animal Models of Alzheimer's Disease
• · Behavior and Treatment
• · Brain Disorder
• · Caregiving and Dementia
• · Cell cycle and AD
• · Dementia during Aging and in Alzheimer's Disease
• · Epidemiology of Alzheimer's Disease
• · Etiology of Alzheimer's Disease
• · Genetics of Alzheimer's Disease
• · Inflammation in Alzheimer's Disease
• · Neural Circuit Dysfunction in Alzheimer’s Disease
• · Neurodegeneration
• · Oxidative Stress and AD
• · Pathogenesis of Alzheimer's Disease
• · Patient Care and Prevention of Alzheimer’s Disease
• · Progress in Alzheimer’s Disease Diagnosis
• · Protein Misfolding
• · Psychosocial Intervention
• · Therapeutic Development
• · Understanding of Alzheimer’s Disease Pathogenesis

We are also interested in: 1) Short Reports – 2-5 page papers where an author can present either an idea with theoretical background but has not yet completed the research needed for a complete paper or preliminary data; 2) Book Reviews – Comments and critiques.